Physician

Benjamin Scott Jones, M.D.

According to 2025 Medicare claims, Benjamin Jones, M.D. (NPI: 1134447980) practices medical oncology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (NPI: 1841216389; TIN: 522170293) and primary practice location at 35243-3509.

Jones' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 612 traditional Medicare patients, billed 288,792 HCPCS/CPT codes, and received $5,199,600 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,618 prescription claims across 598 beneficiaries totaling $7,075,817 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 100 claims. Open Payments data shows 130 records totaling $7,093. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,112 to $5,199,600. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,734 to $7,075,817. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,383 and ending at $2,571.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	27	48	$3,112
2016	183	46,670	$428,489
2017	302	152,734	$1,381,752
2018	401	193,950	$2,457,864
2019	436	259,965	$2,910,886
2020	521	346,310	$4,451,459
2021	602	340,958	$4,959,754
2022	621	405,633	$5,214,245
2023	640	369,710	$4,664,972
2024	612	288,792	$5,199,600

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	24	48	$1,734
2016	59	187	$13,414
2017	138	981	$714,881
2018	221	1,770	$964,875
2019	321	2,363	$2,239,908
2020	360	3,151	$3,522,305
2021	430	3,628	$3,606,779
2022	544	4,391	$4,909,049
2023	581	4,744	$6,247,636
2024	598	4,618	$7,075,817

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	88	$13,793
2018	27	173	$23,874
2019	N/R	61	$5,064
2020	N/R	81	$4,917
2021	13	107	$7,114
2022	N/R	81	$4,473
2023	N/R	66	$12,412
2024	N/R	100	$4,022

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	193	659	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	265	553	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	260	512	$12
36415	Insertion of needle into vein for collection of blood sample	574	2,447	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	548	2,297	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	58	1,730	$806,543
Cabometyx	Cabozantinib S-Malate	32	960	$805,107
Brukinsa	Zanubrutinib	42	1,260	$609,186
Ibrance	Palbociclib	33	889	$519,892
Revlimid	Lenalidomide	34	756	$412,411

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	17	$1,727
J8521	Capecitabine, oral, 500 mg	N	N/R	33	$1,193
E1392	Portable oxygen concentrator, rental	Y	N/R	13	$499
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	25	$452
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	129	$2,403	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$4,690	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Scott Jones, M.D.?

Tedicare shows public-source Medicare data for Benjamin Scott Jones, M.D. (NPI 1134447980), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Scott Jones, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Benjamin Scott Jones, M.D.?

Benjamin Scott Jones, M.D. is linked to BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (billing NPI 1841216389) in the available physician profile data.

Does Benjamin Scott Jones, M.D. have Open Payments data?

Benjamin Scott Jones, M.D. has 130 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.